Nhut M. Le

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Nhut Le, Nhut M Le
Publication record
29 papers · 737 citations · H-index 16

PAPERS

Replacement of Antiretroviral Therapy with HIV Broadly Neutralizing Antibodies to Maximize the Effectiveness of Chemotherapy in HIV Patients with Lung Cancer
20230 citationsauthor #5
Human Hematopoietic Stem Cell (HSC)-Engrafted NSG Mice for HIV Latency Research.
20222 citationsauthor #2
Lamivudine-resistant HIVM184V is Durably Suppressed with Dolutegravir plus Lamivudine Dual Therapy in Humanized Mice.
20201 citationsauthor #4
Disparate effects of Cytotoxic Chemotherapy on the Antiviral Activity of Antiretroviral Therapy: Implications for Treatments of HIV-Infected Cancer Patients
20194 citationsauthor #4
Targeting of CDK9 with indirubin 3’-monoxime safely and durably reduces HIV viremia in chronically infected humanized mice
201718 citationsauthor #4
P-D6 Lasting Reduction Of HIV Replication In Chronically Infected Humanized Mice (HSC-NSG) By Targeting Transcription With A CDK9 Inhibitor
20170 citationsauthor #2
Monotherapy with either dolutegravir or raltegravir fails to durably suppress HIV viraemia in humanized mice
201718 citationsauthor #5
P-D8 Targeting of the catalytic site of host mTOR controls HIV in vivo:
20160 citationsauthor #2
Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized mice
201594 citationsauthor #2
P-A5 Inhibition Of Drug-Resistant HIV By Targeting Cellular CDK9 In Humanized Mice
20140 citationsauthor #2
Targeting host nucleotide biosynthesis with resveratrol inhibits emtricitabine-resistant HIV-1
201425 citationsauthor #4
Indirubin 3′-Monoxime, from a Chinese Traditional Herbal Formula, Suppresses Viremia in Humanized Mice Infected with Multidrug-Resistant HIV
201413 citationsauthor #3
Targeting of the purine biosynthesis host cell pathway enhances the activity of tenofovir against sensitive and drug-resistant HIV-1.
201314 citationsauthor #4
A5 CCR5 Antibodies HGS004 and HGS101 Preferentially Inhibit Drug-Bound CCR5 Infection and Restore Drug Sensitivity of Maraviroc-Resistant HIV-1 in Primary Cells
20121 citationsauthor #2
CCR5 antibodies HGS004 and HGS101 preferentially inhibit drug-bound CCR5 infection and restore drug sensitivity of Maraviroc-resistant HIV-1 in primary cells.
201116 citationsauthor #3
Pharmacotherapy of HIV-1 Infection: Focus on CCR5 Antagonist Maraviroc.
200933 citationsauthor #4
Rapamycin enhances aplaviroc anti-HIV activity: implications for the clinical development of novel CCR5 antagonists.
200916 citationsauthor #5
Reduction of CCR5 with low-dose rapamycin enhances the antiviral activity of vicriviroc against both sensitive and drug-resistant HIV-1
200869 citationsauthor #6
Rapamycin Reduces CCR5 Density Levels on CD4 T Cells, and This Effect Results in Potentiation of Enfuvirtide (T-20) against R5 Strains of Human Immunodeficiency Virus Type 1 In Vitro
200731 citationsauthor #4
CCR5 density levels on primary CD4 T cells impact the replication and Enfuvirtide susceptibility of R5 HIV-1
200752 citationsauthor #4
The Immunomodulatory Agent Rapamycin Potentiates the Antiviral Activity of the Fusion Inhibitor T20 Against R5 Strains of HIV-1
20050 citationsauthor #4
Indirubin-3′-monoxime, a derivative of a Chinese antileukemia medicine, inhibits P-TEFb function and HIV-1 replication
200562 citationsauthor #4
The Immunomodulatory Agent Rapamycin Potentiates the Antiviral Activity of the Fusion Inhibitor T20 Against R5 Strains of HIV-1
20050 citationsauthor #4
Modification and structure-activity relationship of a small molecule HIV-1 inhibitor targeting the viral envelope glycoprotein gp120.
200529 citationsauthor #2
In vitro suppression of latent HIV-1 activation by vitamin E: potential clinical implications
20057 citationsauthor #5
Synthetic bivalent CD4-mimetic miniproteins show enhanced anti-HIV activity over the monovalent miniprotein.
200421 citationsauthor #4
Induction of G1 cycle arrest in T lymphocytes results in increased extracellular levels of β-chemokines: A strategy to inhibit R5 HIV-1
200332 citationsauthor #5
Rapamycin causes down-regulation of CCR5 and accumulation of anti-HIV β-chemokines: An approach to suppress R5 strains of HIV-1
2003134 citationsauthor #4
Abacavir in combination with the inosine monophosphate dehydrogenase (IMPDH)-inhibitor mycophenolic acid is active against multidrug-resistant HIV-1.
199947 citationsauthor #5

TIMELINE

1999 47 citations

2003 166 citations

2004 21 citations

2005 98 citations

2007 83 citations

2008 69 citations

2009 49 citations

2011 16 citations

2012 1 citations

2013 14 citations

2014 38 citations

2015 94 citations

2016 0 citations

2017 36 citations

2019 4 citations

2020 1 citations

2022 2 citations

2023 0 citations

Nhut M. Le

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT